We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current QLGN market cap is 1.51M. The company's latest EPS is USD -2.5896 and P/E is -0.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.44M | 1.39M | 1.61M | 1.63M | 0 |
| Operating Income | -4.38M | -8.65M | -3.69M | -3.55M | -1.15M |
| Net Income | -4.29M | -5.9M | -3.85M | -3.46M | -3.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 2.85M | 5.65M | 4.98M | 0 |
| Operating Income | -10.84M | -11.9M | -22.66M | -22.18M | -11.31M |
| Net Income | -10.13M | -19.55M | -17.9M | -18.64M | -13.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 22.96M | 19.08M | 15.91M | 13.15M | 4.32M |
| Total Liabilities | 7.04M | 10.32M | 9.71M | 9.84M | 5.96M |
| Total Equity | 15.92M | 8.77M | 6.2M | 3.31M | -1.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.8M | 29.13M | 22.84M | 19.08M | 2.03M |
| Total Liabilities | 1.7M | 10.83M | 6.27M | 10.32M | 4.14M |
| Total Equity | 1.1M | 18.3M | 16.57M | 8.77M | -2.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.01M | -13.25M | -2.63M | -5.56M | -4.63M |
| Investing | 61k | -184k | -198k | -246k | 3.98M |
| Financing | 7k | 2.91M | N/A | N/A | -440k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.52M | -10.16M | -14.73M | -13.25M | -10.3M |
| Investing | 7M | -64k | -141k | -184k | 4.22M |
| Financing | 1.41M | 34.05M | 8.43M | 2.91M | -550k |
| Market Cap | 1.51M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.8 |
| Price to Book Ratio | -1.11 |
| Dividend Yield | - |
| Shares Outstanding | 5.18M |
| Average Volume (1 week) | 26.28k |
| Average Volume (1 Month) | 63.81k |
| 52 Week Change | -66.61% |
| 52 Week High | 1.26 |
| 52 Week Low | 0.2831 |
| Spread (Intraday) | 0.02 (7.43%) |
| Company Name | Qualigen Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.qualigeninc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
